Story thread · 2 reports / 2 sources
Abbott wins FDA approval for dual-energy ablation catheter
medtechdive.com · 6d
CEO Robert Ford has said the atrial fibrillation treatment, along with the company's Volt PFA device, is expected to help Abbott regain market share in electrophysiology.
First report: Abbott granted FDA nod for advanced cardiac ablation catheter — seekingalpha.com, 6d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.